Home » Topics » Regulatory » Patents

Patents
RSS

Medshine Discovery identifies new BRD4 inhibitors

March 7, 2022

Chengdu Easton Pharmaceutical synthesizes new mu-opioid receptor agonists

March 7, 2022

Shenzhen Chipscreen Biosciences discloses new PTPN11 inhibitors

March 7, 2022

Chinese investigators patent PAK4 inhibitors

March 7, 2022

BioWorld MedTech Patent Highlights: Week 8

From Current Patent Gazette

March 4, 2022

BioWorld MedTech presents Patent Highlights, an excerpt of the most important med-tech patents from this week's Cortellis Patents Gazette.

Cornell University patents PROTACs targeting BET domain proteins

March 4, 2022

New mucolipin-1 agonists divulged by Casma Therapeutics

March 4, 2022

New prodrugs of PIN1 inhibitors discovered at the University of California

March 4, 2022

Abm Therapeutics identifies new AXL/PAK1/c-KIT/RET/MAP4K1 inhibitors

March 4, 2022

Clarity Pharmaceuticals describes new radiopharmaceuticals

March 4, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...